A Randomised Phase II Study of Irinotecan in Combination with 5-FU/FA Compared with Irinotecan Alone as Second-Line Treatment of Patients with Metastatic Colorectal Carcinoma-Reference-Cited by-同舟云学术

A Randomised Phase II Study of Irinotecan in Combination with 5-FU/FA Compared with Irinotecan Alone as Second-Line Treatment of Patients with Metastatic Colorectal Carcinoma

Published:2007 Issue:4 Volume:30 Page:169-174
ISSN:2296-5270
Container-title:Oncology Research and Treatment
language:en
Short-container-title:Oncol Res Treat

Author:

Graeven Ullrich,Arnold Dirk,Reinacher-Schick Anke,Heuer Theodor,Nusch Arnd,Porschen Rainer,Schmiegel Wolff

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,Hematology

Reference27 articles.

1. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

2. Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of omitting fluorouracil from FOLFIRI plus bevacizumab as second-line chemotherapy for patients with metastatic colorectal cancer;Journal of Cancer Research and Clinical Oncology;2022-03-22

2. Weekly High-dose 5-Fluorouracil as 24-hour Infusion Combined with Sodium Folinic Acid (AIO regimen) Plus Irinotecan in Second-line and Sequential Therapy of Metastatic Colorectal Cancer (CRC);Anticancer Research;2017-07-05

3. Effects of an irinotecan derivative, ZBH-1208, on the immune system in a mouse model of brain tumor and its antitumor mechanism;Molecular Medicine Reports;2017-05

4. Second-line systemic therapy for metastatic colorectal cancer;Cochrane Database of Systematic Reviews;2017-01-27

5. Maintenance Therapy in Colorectal Cancer: Moving the Artillery Down While Keeping an Eye on the Enemy;Clinical Colorectal Cancer;2016-03